期刊
CANCER LETTERS
卷 451, 期 -, 页码 34-47出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2019.02.052
关键词
Head and neck squamous cell carcinoma; Interferon-alpha; Hydroxychloroquine; Wortmannin; Autophagy
类别
资金
- National Natural Science Foundation of China [81472516, 81872185, 31140007, 81772870, 81472517]
- Natural Science Foundation of Shanghai [14ZR1424200]
- Shanghai Leading Academic Discipline Project [S30206]
- Doctoral Innovation Fund of Shanghai Jiao Tong University School of Medicine [BXJ201728]
Despite multiple antitumor activities, interferon-alpha (IFN alpha) therapy alone is less effective in solid tumors. Autophagy has been reported to play a key role in tumor chemoresistance. Therefore, it is meaningful to explore whether autophagy can be activated by IFN alpha in head and neck squamous cell carcinoma (HNSCC) and serve as a potential target to improve efficacy of IFN alpha therapy. In this study, we report that IFN alpha not only exhibits anti proliferation activity and induces apoptosis, but also activates autophagy in HNSCC cells. Moreover, silencing autophagy-related protein 5 (ATG5) and signal transducer and activator of transcription 1 (STAT1) suppresses autophagy flux. Furthermore, IFN alpha and autophagy inhibitors (hydroxychloroquine and wortmannin) show clear synergistic effects on inhibiting growth and promoting apoptosis in HNSCC cells and xenograft models. Our findings indicate that IFN alpha-induced autophagy plays a cytoprotective role and blocking autophagy flux promotes IFN alpha-mediated apoptosis in HNSCC. These results suggest that the combination of IFN alpha and autophagy inhibitors represents a novel strategy for HNSCC treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据